Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and ...

Microarray technology has come of age as a powerful approach to revealing the genome and its dynamic expression through the application of gene-hybridization or gene-expression microarrays. While the ...

Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

Understanding gene expression is a cornerstone of modern molecular biology and biomedical research. Whether studying disease mechanisms, drug responses, or developmental biology, accurate gene ...

Microarrays spotted with oligonucleotides, DNA, RNA and proteins have been routinely used as tools for expression profiling for more than a decade. What’s exciting about this technology is that it has ...

Microarray technology could be used to tailor therapy according to the individual, and prevent breast cancer patients from having to undergo painful unsuccessful therapies. In a study published in the ...

Next generation genomics technology is playing a significant role in improving the outcomes of genomic tools used in livestock farming, cultivation of crops, selection of quality seeds with improved ...

Current microarray analysis uses 'chips' containing either 25-residue oligonucleotides synthesized by photolithography or cDNAs placed by robotic spotting. In the April Nature Biotechnology, Hughes et ...

Ariosa Diagnostics announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony Non-Invasive Prenatal Test SAN JOSE, California, ...

Mutant alleles of dominant, highly penetrant breast cancer genes, including BRCA1 and BRCA2, do not occur frequently, and hence account for only a small proportion of breast cancer cases. On the other ...